Shell Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Sell |
1,786
-171
| -9% | -$4.12K | ﹤0.01% | 1170 |
|
|
2025
Q1 | $49K | Sell |
1,957
-74
| -4% | -$1.85K | ﹤0.01% | 1152 |
|
|
2024
Q4 | $38K | Hold |
2,031
| – | – | ﹤0.01% | 1204 |
|
|
2024
Q3 | $31K | Buy |
+2,031
| New | +$31K | ﹤0.01% | 1213 |
|
|
2024
Q1 | $53K | Sell |
1,858
-246
| -12% | -$7.02K | ﹤0.01% | 1151 |
|
|
2023
Q4 | $71K | Sell |
2,104
-635
| -23% | -$21.4K | ﹤0.01% | 1126 |
|
|
2023
Q3 | $84K | Sell |
2,739
-42
| -2% | -$1.29K | ﹤0.01% | 1119 |
|
|
2023
Q2 | $111K | Sell |
2,781
-16
| -0.6% | -$639 | ﹤0.01% | 1101 |
|
|
2023
Q1 | $114K | Sell |
2,797
-10
| -0.4% | -$408 | ﹤0.01% | 1069 |
|
|
2022
Q4 | $108K | Sell |
2,807
-604
| -18% | -$23.2K | ﹤0.01% | 1137 |
|
|
2022
Q3 | $181K | Sell |
3,411
-885
| -21% | -$47K | 0.01% | 1047 |
|
|
2022
Q2 | $250K | Buy |
4,296
+1,000
| +30% | +$58.2K | 0.01% | 1051 |
|
|
2022
Q1 | $252K | Sell |
3,296
-487
| -13% | -$37.2K | 0.01% | 1106 |
|
|
2021
Q4 | $228K | Buy |
3,783
+12
| +0.3% | +$723 | ﹤0.01% | 1174 |
|
|
2021
Q3 | $211K | Sell |
3,771
-160
| -4% | -$8.95K | ﹤0.01% | 1187 |
|
|
2021
Q2 | $239K | Buy |
3,931
+2,518
| +178% | +$153K | ﹤0.01% | 1183 |
|
|
2021
Q1 | $99K | Buy |
+1,413
| New | +$99K | ﹤0.01% | 1290 |
|